Nanobiotix SA

Nanobiotix SA

25.24
EUR
-1.00
(-3.81%)
1.65BMarket Cap
Apr 27Next Earn

Total Valuation

EUR

As of June 30, 2026, Nanobiotix SA carries a market capitalization of 1.65B, placing it among publicly traded companies globally. Its enterprise value stands at 1.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.65B
Enterprise Value1.64B

Important Dates

Nanobiotix SA's next confirmed earnings release is scheduled for April 27, 2027.

Earnings Date4/27/2027

Share Statistics

As of June 30, 2026, Nanobiotix SA has 50.80M shares outstanding.

Shares Outstanding50.80M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio-49.34
P/TBV Ratio-49.33

Financial Position

As of June 30, 2026, Nanobiotix SA maintains a current ratio of 1.44, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.44
Quick Ratio1.40
Debt / Equity-319.37

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count97.00

Stock Price Statistics

EUR

As of the close on November 17, 2026, Nanobiotix SA's stock has gained approximately 32.42% over the past 52 weeks. The 50-day moving average sits at 26.40, while the 200-day moving average is 29.83.

52-Week Price Change32.42%
50-Day Moving Average26.40
200-Day Moving Average29.83

Balance Sheet

EUR

As of June 30, 2026, Nanobiotix SA holds 110.89M in cash and equivalents against 106.61M in total debt, resulting in a net debt position of -6.78M. Total book value stands at -33.38M, with working capital of 37.55M providing operational flexibility.

Cash & Cash Equivalents110.89M
Total Debt106.61M
Net Debt-6.78M
Equity (Book Value)-33.38M
Book Value Per Share-0.66
Working Capital37.55M

Stock Splits

Nanobiotix SA's most recent stock split took place on February 25, 2014.

Last Split Date2/25/2014